Home / Health / Shingles Vaccine Cuts Heart Risk Dramatically
Shingles Vaccine Cuts Heart Risk Dramatically
25 Mar
Summary
- Shingles vaccine linked to significantly fewer heart complications.
- Study analyzed over 246,000 adults with arterial plaque buildup.
- Vaccine benefits comparable to quitting smoking, researchers state.
New research indicates that the shingles vaccine may provide substantial cardiovascular health advantages. A study presented on March 30, 2026, analyzed health records of over 246,000 adults in the United States with atherosclerotic cardiovascular disease. The findings suggest that individuals who received the shingles vaccine experienced markedly fewer heart-related complications within one year compared to those unvaccinated.
The analysis revealed that vaccination was linked to a lower risk across all studied cardiac outcomes. Researchers highlighted that these reductions are substantial, with some benefits comparable to the advantages gained from quitting smoking. This strengthens existing recommendations for all adults aged 50 and older to receive the shingles vaccine.
Previous research suggested that shingles infection itself could increase the risk of future cardiovascular events by nearly 30%. By preventing shingles, the vaccine may inherently mitigate these associated cardiovascular risks. While the study's observational nature means direct causation cannot be proven, the large dataset and statistical methods used bolster confidence in these promising results, adding to the evidence of broader health benefits from shingles vaccination.
